Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors

NCT06742593 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain (Nervous System) Cancers
Brain and Central Nervous System Tumors
Brain Tumors

Interventions

DRUG: MT027 cells suspension

Sponsor

Suzhou Maximum Bio-tech Co., Ltd.